About Swift biosciences, inc
Swift Biosciences, Inc: Revolutionizing Genomic Research with Innovative Solutions
Swift Biosciences, Inc is a leading provider of innovative genomic solutions that enable researchers to unlock the full potential of their research. The company has been at the forefront of developing cutting-edge technologies that have revolutionized genomic research and helped scientists to make significant breakthroughs in various fields.
Founded in 2010, Swift Biosciences has quickly established itself as a trusted partner for researchers worldwide. The company's mission is to provide high-quality products and services that empower scientists to achieve their research goals faster and more efficiently.
One of the key strengths of Swift Biosciences is its expertise in next-generation sequencing (NGS) library preparation and enrichment. The company's proprietary technologies are designed to streamline workflows, reduce costs, and improve data quality. Swift BioScience library preparation and enrichment products are widely used by researchers across various applications such as cancer genomics, microbiome analysis, metagenomics, epigenetics, transcriptomics among others.
In 2020 IDT (Integrated DNA Technologies), a leading manufacturer of custom nucleic acid products acquired Swift Biosciences. This acquisition brought together two industry leaders with complementary product portfolios creating an even stronger offering for customers worldwide.
Swift Biosciences' flagship product line xGen™ NGS portfolio includes both library preparation kits for whole-genome sequencing (WGS), targeted resequencing panels for exome sequencing or custom gene panels as well as unique hybridization capture probes for target enrichment applications such as RNA-seq or ChIP-seq experiments.
The xGen™ NGS portfolio offers several advantages over traditional methods such as PCR-based amplification or hybridization capture using biotinylated probes. These advantages include higher sensitivity due to reduced bias introduced during amplification steps; improved specificity due to optimized probe design; increased flexibility allowing customization based on specific experimental needs; reduced cost per sample due to lower input requirements; faster turnaround time from sample-to-answer compared with other methods available on the market today.
Swift Bioscience's innovative solutions have been recognized by numerous awards including Frost & Sullivan’s Best Practices Award for Product Innovation in Nucleic Acid Sample Preparation Products category in 2018 which highlights the impact these technologies have had on advancing scientific discovery globally.
The company also offers customized services tailored specifically towards individual customer needs including assay development support from experienced scientists who can help optimize experimental conditions based on specific project requirements ensuring successful outcomes every time!
In conclusion,
Swift Bioscience's commitment towards innovation has made it one of the most trusted names in genomic research today. With its cutting-edge technology platforms like xGen™ NGS portfolio coupled with world-class customer service support team makes it an ideal partner for any researcher looking forward to making significant breakthroughs in their field while reducing costs associated with traditional methods available today!